medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2019, Número 627

<< Anterior Siguiente >>

Rev Med Cos Cen 2019; 85 (627)


Actualización de las guías de la Sociedad Europea de Cirugía Vascular de manejo de enfermedad ateroesclerótica carotídea del 2017

Martínez ME, Huete MF, Hernández GA, Odio ZP, Barboza EMA

Idioma: Español
Referencias bibliográficas: 37
Paginas: 8-15
Archivo PDF: 119.50 Kb.


RESUMEN

El ictus isquémico es la segunda causa de muerte a nivel mundial, y es una de las principales causas de discapacidad. Aproximadamente un 15% de los ictus, son causados por la enfermedad ateroesclerótica de los vasos del cuello. La detección de esta enfermedad, así como el manejo para atacarla son piezas claves en la prevención del ictus, así como la diminución de su impacto en os sistemas de salud. Para la elaboración del siguiente documento, se tomaron las Guías de manejo de enfermedad ateroesclerótica de carótidas y arterias vertebrales de la Sociedad Europea de Cirugía Vascular, y se propuso realizar una actualización a dicho documento con los datos más actuales al momento de la realización de este. Para tal objetivo, ser realizó una búsqueda bibliográfica en bases de datos indexadas. Cada paciente con enfermedad carotídea debe ser abordado según su condición clínica, porcentaje de obstrucción, presencia o no de enfermedad sintomática y comorbilidades. El manejo no debe ser quirúrgico en todos los casos, pero en los casos que, si lo requieran, se debe abordar de manera expedita. El control de factores de riesgo y el manejo médico son de una importancia crítica en el manejo de esta patología.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cole, J. Large artery atherosclerotic occlusive disease. Continuum Journal. American Academy of neurology, 2017;23(1):133–157

  2. Gokaldas, R. et al. Carotid Stenosis: From Diagnosis to Management, Where Do We Stand? Curr Atheroscler Rep (2015) 17:1

  3. Dharmakidar, S. et al. Carotid Artery Stenosis: Medical Therapy, Surgery, and Stenting. Curr Neurol Neurosci Rep (2017) 17:77

  4. Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Scarborough P, Rayner M. European cardiovascular disease statistics 2012. Sophia Antipolis: European Heart Network, Brussels, European Society of Cardiology. www.escardio.org/ static_file/.../EU-Cardiovascular-disease-statistics-2012.pdf

  5. Lanza, G, et al. Carotid Artery Stenting: Second Consensus Document of the ICCS/ISO-SPREAD Joint Commitee. Cerebrovasc Dis 2014;38:77–93

  6. Aho K,Harmsen P,Hatano S,MarquardsenJ, SmirnovVE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58:113e30.

  7. de Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB, O’Leary DH, et al. Prediction of asymptomatic carotid artery stenosis in the general population identification of high-risk groups. Stroke 2014;45:2366e71

  8. Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess 2006;10:1e182

  9. Herder M, Johnsen SH, Arntzen KA, Mathiesen EB. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromso Study. Stroke 2012;43:1818e23

  10. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a metaanalysis. Stroke 2003;34:2475e81

  11. Strazzullo P, D’Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: metaanalysis of prospective studies with 2 million participants. Stroke 2010;41:e418e26.

  12. King A, Shipley M, Markus H. for the ACES Investigators. The effect of medical treatments on stroke risk in asymptomatic carotid stenosis. Stroke 2013;44:542e6

  13. Stone N, Robinson J, Lichtenstein AH, Merz NB, Blum CB, Exkel RH. 2013 ACC/AHA guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2889e934

  14. Sutton-Tyrrell K,Wolfson Jr SK, Kuller LH. Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension. Stroke 1994;25:44e50

  15. Law MR, Morris JK,Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665

  16. Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, et al. Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke 2012;43:1212e7.

  17. Zhang C, Zhou YH, Xu CL, Chi FL, Ju HN. Efficacy of intensivecontrol of glucosa in stroke prevention: a meta-analysis of data from 59197 participants in 9 randomized controlled trials. PLoS One 2013;8:e54465.

  18. A.R. Naylor et al. Editor’s Choice e Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) Eur J Vasc Endovasc Surg (2018) 55, 3e81

  19. Hirt LS. Progression rate and ipsilateral neurological events in asymptomatic carotid stenosis. Stroke 2014;45:702e6.

  20. Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzger DC, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. NEJM 2016;374:1011e20.

  21. Rothwell PM, Algra A, Chen Z, Diener H-C, Norvving B, Mehta Z. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: timecourse analysis of randomised trials. Lancet 2016;388:365e75.

  22. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369:11e9.

  23. Navarese EP, Andreotti F, Schulze V, Kolodziejczak M, Buffon A, Brouwer M, et al. Optimal duration of dual antiplatelet therapy after percutaneous coronary interventions with drug eluting stents: meta-analysis of randomised trials. BMJ 2015;350:L1618

  24. Angiolillo DJ, Gibson CM, Cheng S, Ollier C, Nicolas O, Bergougnan L, et al. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomised, placebo controlled crossover comparison studies. Clin Pharmacol Ther 2011;89:65e74

  25. Abraham NS. Prescribing proton pump inhibitors and clopidogrel together: current state of recommendations. Curr Opin Gastroenterol 2011;27:558e64.

  26. Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2014;10:CD000039.

  27. Bond R, Narayan S, Rothwell PM, Warlow CP. on behalf of the European Carotid Surgery Trialists’ Collaborative Group. Clinical and radiological risk factors for operative stroke and death in the European Carotid Surgery Trial. Eur J Vasc Endovasc Surg 2002;23:108e16

  28. Naylor AR, Sayers RD, McCarthy MJ, Bown MJ, Nasim A, Dennis M, et al. Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy. Eur J Vasc Endovasc Surg 2013;46:161e70

  29. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281e357

  30. Howard G, Roubin GS, Jansen J, Halliday A, Fraedrich G, Eckstein H-H. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. Lancet 2016;387:1305e11.

  31. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis inrelation to clinical subgroups and timing of surgery. Lancet 2004;363:915e24

  32. Sharpe R, Sayers RD, London NJ, Bown MJ, McCarthy MJ, Nasim A, et al. Procedural risk following carotid endarterectomy in the hyperacute period after onset of symptoms. Eur J Vasc Endovasc Surg 2013;46:519e24.

  33. Karkos CD, McMahon G, McCarthy MJ, Dennis MJ, Sayers RD, London NJ, et al. The value of urgent carotid surgery for crescendo transient ischemic attacks. J Vasc Surg 2007;45: 1148e54.

  34. Bartoli MA, Squarcioni C, Nicoli F, Magnan PE, Malikov S, Berger L, et al. Early carotid endarterectomy after intravenous thrombolysis for acute ischaemic stroke. Eur J Vasc Endovasc Surg 2009;37:512e8.

  35. Nandalur MR, Cooper H, Satler LF, Nandalur KR, Laird Jr JR. Vasopressor use in the critical care unit for treatment of Management of Atherosclerotic Carotid and Vertebral Artery Disease 77 persistent post-carotid artery stent induced hypotension. Neurocrit Care 2007;7:232e7.

  36. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/ CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guidelines on the management of patients with extracranial carotid and vertebral artery disease. J Am Coll Cardiol 2011;57:1002e44

  37. Ameriso. S, Romano. M. Manejo de la estenosis carotídea severa asintomática. Neurología Argentina, 2010; 2(4): 247-249




2020     |     www.medigraphic.com